Adverse events28

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

21 to 28 of 28

Type	Event	Organ system	Group	Affected	At risk
other	Nasopharyngitis	Infections and infestations	Afamelanotide	3	15
other	Nasopharyngitis	Infections and infestations	Placebo	3	16
other	Back pain	Musculoskeletal and connective tissue disorders	Afamelanotide	1	15
other	Back pain	Musculoskeletal and connective tissue disorders	Placebo	2	16
other	Gastritis	Gastrointestinal disorders	Afamelanotide	0	15
other	Gastritis	Gastrointestinal disorders	Placebo	1	16
other	Influenza	Infections and infestations	Afamelanotide	1	15
other	Influenza	Infections and infestations	Placebo	0	16

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04704713/events?page=2